Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe first few days on Mounjaro are often quieter than people expect. Most people feel little beyond a mild awareness that something is different — appetite shifts slightly, and some notice a faint nausea that comes and goes. You've started at 2.5mg, the lowest available strength, precisely because the first pen's job is to settle your system rather than drive weight loss. Mounjaro (tirzepatide) is a prescription-only medicine; a GPhC-registered prescriber will have assessed your suitability before a single dose was dispensed. What happens next, hour by hour and day by day, is what this page covers. The NHS patient information for tirzepatide is a useful companion, and our own guide to your first day on Mounjaro goes deeper on the hours immediately after injection.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
You did the injection, you put the pen back in the fridge, and... not much happened. That's the most common scenario. Mounjaro activates two gut-hormone receptors, GIP and GLP-1, which together slow gastric emptying and reduce appetite signals reaching the brain. At 2.5mg, those effects are gentle by design. Eli Lilly built the dose ladder so that each step up is earned gradually, reducing the chance of a rough first week.
Some people notice a background nausea in the twelve to thirty-six hours after their first injection. It rarely stops people going about their day. If you want to know exactly what to expect as those first hours unfold, our guide to the first 24 hours on Mounjaro walks through the timeline in detail. Eating smaller portions, sticking to plain food for the first couple of days, and drinking steadily through the day all help. Fatty or very rich meals make the nausea considerably worse, so most people find it easier to lean towards lighter food naturally, the appetite drop tends to encourage that anyway.
A question our prescribers hear most weeks is whether feeling almost nothing means the medicine isn't working. It doesn't. The 2.5mg starter dose isn't calibrated to produce dramatic results; it's calibrated to produce a good start. Consistent dosing matters far more at this stage than any immediate sign of effect. Our page on whether Mounjaro's effect wears off in the first days covers this in detail.
The side-effect profile in the opening days is almost always gastrointestinal. Nausea is the most reported, followed by loose stools or constipation (both can happen, at different times), burping, and a general feeling of fullness that arrives faster than expected at mealtimes. These are listed in the NHS tirzepatide patient information as common effects, and the clinical trial data showed they were mostly mild-to-moderate and settled within days to a couple of weeks for most participants.
Headache and tiredness appear occasionally, usually linked to eating less without adjusting hydration. Keeping fluid intake steady (plain water, herbal tea, diluted soft drinks) makes a real difference.
Two side effects warrant prompt medical attention and should not be waited out. First: severe stomach pain that doesn't ease and radiates toward the back, with or without vomiting. The MHRA issued a Drug Safety Update in January 2026 flagging acute pancreatitis as an infrequent but serious risk across GLP-1 medicines, if this describes your pain, seek urgent help rather than managing it at home. Second: signs of a serious allergic reaction such as facial swelling, difficulty breathing, or a spreading rash. These are rare but need emergency care. Patients can also report side effects directly to the MHRA via the Yellow Card scheme.
Everything else (mild nausea, a brief headache, one or two unsettled nights) is the body adjusting. It passes.
There's no special Mounjaro diet, Mounjaro is prescribed alongside a reduced-calorie approach and more activity, not as a replacement for them. In the first few days, though, the practical priority is simply not making the side effects worse. That means smaller meals, slower eating, less fat, adequate protein, and plenty of water.
Appetite suppression means it's easy to undereat to the point of fatigue. Protein is particularly important to protect muscle tissue during weight loss, so even when portions feel smaller than usual, try to include a protein source at each meal. Your prescriber or a registered dietitian can help you shape a longer-term plan, that's beyond what any online resource should prescribe specifically for you.
Physical activity doesn't need to stop. Gentle walking is fine from day one. If you feel nauseated or tired after the injection day, scaling back intensity briefly and returning when you feel ready is a sensible, common-sense approach.
If you're still finding your feet with the injection itself (technique, rotating sites, what to do if a dose is delayed) our page on taking Mounjaro for the first time covers the practical detail. And if you want a broader picture of how tirzepatide works before considering whether treatment is right for you, our tirzepatide compund page is a good starting point. For context on what the private prescription process involves, including Mounjaro pricing in the UK, that information is available separately.
If anything feels off or you have questions as you go, our clinical team is available seven days a week. Speak to our prescribers through the consultation page at any point.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.